If only one or none such mutation was identified in patients highly suspected to have NICCD, Sanger sequencing of all the SLC25A13 exons and their flanking sequences would be performed to identify the possible novel mutation [11, 25, 33–35]. Here, SLC25A13 is linked to neonatal intrahepatic cholestasis due to citrin deficiency.